País: Alemania
Idioma: inglés
Fuente: HMA (Heads of Medicines Agencies)
carprofen 50 mg/ml
Ecuphar N.V.
QM01AE91
solution for injection or infusion
carprofen
Cats Non Food, Dogs Non Food
2012-08-17
PART 1 B1 SUMMARY OF PRODUCT CHARACTERISTICS (SPC) SPC FOR ‘ACTICARP SA 50 MG/ML SOLUTION FOR INJECTION FOR DOGS AND CATS’ PRESENTED IN SUBSEQUENT PAGES, 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AT: Acticarp SA 50 mg/ml Injektionslösung für Hunde und Katzen BE: Acticarp SA 50 mg/ml Oplossing voor injectie voor honden en katten CZ: Acticarp SA 50 mg/ml Injekční roztok pro psy a kočky DE: Acticarp SA 50 mg/ml Injektionslösung für Hunde und Katzen LU: Acticarp SA 50 mg/ml Solution injectable pour chiens et chats NL: Acticarp SA 50 mg/ml Oplossing voor injectie voor honden en katten PT: Acticarp SA 50 mg/ml Solução injectável para cães e gatos SK: Acticarp SA 50 mg/ml Injekĉný roztok pre psov a mačky 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains : ACTIVE SUBSTANCE: Carprofen 50 mg EXCIPIENTS: Benzyl alcohol 10 mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM A clear pale yellow to yellowish solution for injection. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats (cats as from the age of 5 months). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Dogs: For the reduction of post-operative pain and inflammation following orthopaedic and soft tissue (including intra-ocular) surgery. Cats: For the control of post-operative pain after small surgical procedures 4.3 CONTRAINDICATIONS Do not use in animals suffering f Leer el documento completo